🇺🇸 FDA
Patent

US 11667702

Stable aqueous formulations of aflibercept

granted A61KA61K38/179A61K47/02

Quick answer

US patent 11667702 (Stable aqueous formulations of aflibercept) held by Coherus BioSciences, Inc. expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Coherus BioSciences, Inc.
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/179, A61K47/02, A61K47/10, A61K47/12